The Board of Governors is the body responsible for the Institute; it approves and monitors budgets and scientific progress.
Chaired by Dr Stephen Hollings, the board comprises nominees from the Cardiologists of Royal Prince Alfred Hospital, the Central Sydney Area Health Service, the Medical Deans of Australia, the National Heart Foundation, the NSW Ministry of Health, the University of Sydney and the Vice-Chancellors of the Universities in NSW, together with the Director of the institute. The majority of the board positions are available to be filled by election by the members of the incorporated company, The Heart Research Institute Ltd, to represent the corporate and scientific community.
Stephen Hollings was appointed to the role of Director of Sales Strategy at News Limited in April 2009 after having been Chief Executive of CareerOne for the previous two-and-a-half years. In early 1997 he joined News Limited as group classified advertising director, before becoming Strategic Development Director of Advertising for News Limited in 2004. Stephen, who has a PhD in history, is Chairman of the Audit Bureau of Circulations, a Foundation Fellow of the Institute of Company Directors, and an Honorary Life Fellow of the International Marketing Institute of Australia.
Michael Davies is the Director of The Heart Research Institute and has led the Free Radical Group since 1995. In 1996 he was awarded a QEII Fellowship, in 2000 a Senior Fellowship, and in 2009 a Professorial Fellowship of the Australian Research Council (ARC). In 2004 he was appointed as a Conjoint Professor at The University of Sydney and a Fellow of the Royal Australian Chemical Institute.
Teresa Anderson is Chief Executive of the Sydney Local Health District and has over 30 years' experience as a clinician and manager in the public health system, including General Manager, Liverpool Hospital and Director, Clinical Operations, Former Sydney South West Area Health Service. Dr Anderson is also a Board member of the Ingham Health Research Institute, Anzac Research Institute, Centre for Primary Health Care and Equity, and Inner West Sydney Medicare Local.
John Batistich is Director of Marketing for the Westfield Group. He has over 20 years of experience in Research, Marketing and General Management with blue chip companies. Marketing communications led by John have won a Cannes Lion award and an Australian Advertising Effectiveness Award. John is a member of the Australian Market & Social Research Society Client Advisory Board, and the Australian Research Awards judging panel. John holds a Masters in Management degree from MGSM majoring in Human Resources, a Bachelor of Business degree from the University of Western Sydney majoring in Marketing, and a Certificate in Digital Marketing from ADMA.
Barry Brownjohn is a non-executive Director of Dexus Funds Management Limited, Citigroup Pty Ltd, an Advisory Board Member of the South Australian Financing Authority and a Director of Bakers Delight Holdings Pty Limited. Barry has over 20 years’ experience in international banking in North America, Asia and Australia. Much of this time was with Bank of America where his responsibilities included heading global risk management for the capital markets business, the Asia capital markets business and Australasian CEO between 1991 and 1996. He has also served in numerous industry positions including Chairing the International Banks and Securities Association in Australia and The Asia Pacific Managed Futures Association. Following his career with Bank of America, Barry has been active in advising companies on strategic expansion and capital raising strategies with assignments encompassing a wide range of venture capital and fundraising activities for companies based in Australia and overseas.
Craig Davison has been Managing Director of Gordon and Gotch since September 2005. Prior to this, Craig held Manager Director positions in the Security, Recruitment and Logistics sectors, where he drove and managed change programs across a wide range of industries, including FMCG, distribution, retailing and logistics. His wealth of experience in leading complex, time sensitive service businesses has succeeded in financial optimisation, acquisition and divestment in Australia, the United States and United Kingdom. Craig became involved with the Heart Research Institute because heart disease has touched his life and he sees great value in helping the work of our amazing research team. Craig has qualifications in Marketing and Management and is a member of Australian Institute of Management.
Josette Eris graduated from the University of Sydney with first class honours and undertook nephrology training at Royal Prince Alfred Hospital. She became a fellow of the RACP in 1989. She undertook research in the field of basic immunology culminating in a PhD from the University of Sydney for the study of Cellular interactions in a transgenic model of self tolerance. Josette Eris is the Head of Department of State Wide Renal Services at Royal Prince Alfred Hospital. She is also the current President of the Transplantation Society of Australia and New Zealand (TSANZ) and has been on its Council for 8 years.
Wendy Jessup completed her tertiary scientific training at the Universities of Manchester and Sheffield in the United Kingdom. She moved to Australia in 1989 to take up a position at The Heart Research Institute. She was promoted to leader of the Cell Biology Group in 1994 later also becoming Deputy-Director until shortly before her departure in 2002. Until the end of 2012 she was a Principal Research Fellow at the National Health and Medical Research Council (NHMRC) and a Professor and Principal Research Fellow in the Faculty of Medicine at the University of New South Wales where she co-led the Macrophage Biology Group in the Centre for Vascular Research. She is now a Principal Research Fellow in the Atherosclerosis Laboratory at the ANZAC Research Institute.
Len Kritharides is Head of Department and Director of Cardiology at Concord Repatriation General Hospital (CRGH) Sydney, Professor of Medicine at The University of Sydney, Head of the Atherosclerosis Research Laboratory Group at the ANZAC Research Institute, and Deputy Clinical Director of the Cardiovascular Stream of the Sydney Local Health District. He completed his undergraduate degree at the University of Melbourne, his Postgraduate Physician training in Cardiology at the Royal Melbourne Hospital, and in 1994 he completed a PhD in macrophage biology at The Heart Research Institute in Sydney. After postdoctoral research at the HRI and in the USA, he took up an appointment as Staff Specialist in Cardiology at Concord Hospital 1998, and became Head of Department in 2003. He was awarded a NSW Government Community Services Award for his contribution to Concord Repatriation General Hospital by the Premier Morris Iemma in 2006. He is former Board Member and Chair of the Scientific Committee of the Cardiac Society of Australia and New Zealand, and regularly serves on review panels for the National Heart Foundation and the NHMRC.
Joann Lewis is a senior adviser at Aquasia. She has 18 years’ experience in the finance sector providing clients with M&A advisory services and assurance based advice. Joann has previously worked in Investment Banking at Royal Bank of Scotland, ABN AMRO, Commonwealth Bank of Australia and PricewaterhouseCoopers and prior to that as an auditor for PricewaterhouseCoopers in Sydney, London and Frankfurt. Her qualifications include Bachelor of Commerce from University of New South Wales, Chartered Accountant from ICAA and Graduate Diploma in Applied Finance and Investment from Finsia. Joann became involved with The Heart Research Institute because, as for so many people, heart disease has touched her life and she sees great value in helping the work of our amazing researchers.
William C. Stanley received his PhD in exercise physiology at the University of California, Berkeley. He has worked at a number of prominent US universities, including the University of California, San Francisco, University of Wisconsin and the University of Maryland. In addition to this he has spent 4 years outside of academic research, doing cardiovascular drug discovery for the pharmaceutical industry. In 2013 he moved to Australia to become Chair of Cardiovascular Physiology at the University of Sydney, where his research program addresses questions regarding the role of energy metabolism and diet in the pathophysiology of heart failure and ischemic injury. He is a recognised expert on cardiac metabolism and physiology, and is the Editor in Chief of the American Journal of Physiology – Heart & Circulation.